Skip to content
healthcare.dev

Oxymetazoline Hydrochloride 12-Hour

NDC 51672-2030, Oxymetazoline Hydrochloride, spray, from Sun Pharmaceutical Industries, Inc..

Product NDC
51672-2030
Status
Listed
Labeler
Sun Pharmaceutical Industries, Inc.
Dosage form
SPRAY
Route
NASAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M012
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51672-2030 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXYMETAZOLINE HYDROCHLORIDE.05 g/100mL

Pharmacologic classes

Imidazolines [CS]; Increased Sympathetic Activity [PE]; Vasoconstriction [PE]; Vasoconstrictor [EPC]

Package NDCNDC-11Package
51672-2030-3516722030031 BOTTLE, SPRAY in 1 CARTON (51672-2030-3) / 30 mL in 1 BOTTLE, SPRAY
51672-2030-5516722030051 BOTTLE, SPRAY in 1 CARTON (51672-2030-5) / 15 mL in 1 BOTTLE, SPRAY

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 51672-2030 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51672-2030 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51672-2030. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.